KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) EBITDA Margin: 2009-2025

Historic EBITDA Margin for Thermo Fisher Scientific (TMO) over the last 17 years, with Sep 2025 value amounting to 17.45%.

  • Thermo Fisher Scientific's EBITDA Margin rose 11.00% to 17.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.16%, marking a year-over-year increase of 23.00%. This contributed to the annual value of 17.11% for FY2024, which is 111.00% up from last year.
  • According to the latest figures from Q3 2025, Thermo Fisher Scientific's EBITDA Margin is 17.45%, which was up 3.29% from 16.90% recorded in Q2 2025.
  • Thermo Fisher Scientific's EBITDA Margin's 5-year high stood at 30.78% during Q2 2021, with a 5-year trough of 14.59% in Q2 2023.
  • Over the past 3 years, Thermo Fisher Scientific's median EBITDA Margin value was 17.03% (recorded in 2023), while the average stood at 16.66%.
  • In the last 5 years, Thermo Fisher Scientific's EBITDA Margin skyrocketed by 1,624bps in 2021 and then crashed by 928bps in 2023.
  • Quarterly analysis of 5 years shows Thermo Fisher Scientific's EBITDA Margin stood at 23.72% in 2021, then tumbled by 746bps to 16.25% in 2022, then skyrocketed by 78bps to 17.03% in 2023, then soared by 66bps to 17.69% in 2024, then increased by 11bps to 17.45% in 2025.
  • Its last three reported values are 17.45% in Q3 2025, 16.90% for Q2 2025, and 16.56% during Q1 2025.